Home » Stocks » BioCorRx

BioCorRx Inc. (BICX)

Stock Price: $2.73 USD 0.27 (10.98%)
Updated Aug 13, 2020 4:00 PM EDT - End of day

Stock Price Chart

Key Info

Market Cap 14.65M
Revenue (ttm) 211,880
Net Income (ttm) -5.34M
Shares Out 5.37M
EPS (ttm) -1.27
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 13, 2020
Last Price $2.73
Previous Close $2.46
Change ($) 0.27
Change (%) 10.98%
Day's Open 2.45
Day's Range 1.98 - 2.73
Day's Volume 3,870
52-Week Range 1.50 - 4.02

More Stats

Market Cap 14.65M
Enterprise Value 13.07M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 5.37M
Float 2.66M
EPS (basic) -1.25
EPS (diluted) -1.27
FCF / Share -0.63
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta 1.42
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 69.14
PB Ratio 209.37
Revenue 211,880
Operating Income -5.60M
Net Income -5.34M
Free Cash Flow -3.37M
Net Cash 1.58M
Net Cash / Share 0.29
Gross Margin 74.85%
Operating Margin -2,642.33%
Profit Margin -2,518.30%
FCF Margin -1,591.91%
ROA -144.63%
ROE n/a
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$9.00*
Low
9.00
Current: $2.73
High
9.00
Target: 9.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue0.240.380.660.700.921.170.710.870.770.14
Revenue Growth-36.21%-42.69%-6.34%-24.11%-21.03%63.77%-17.65%12.49%434.46%-
Gross Profit0.160.210.330.530.770.950.550.470.37-0.01
Operating Income-5.56-4.63-2.89-2.05-1.48-3.05-2.50-0.62-0.34-0.15
Net Income-6.04-6.51-29.71-5.90-4.67-3.13-3.84-0.89-0.41-0.15
Shares Outstanding3.522.512.331.701.551.391.171.060.510.37
Earnings Per Share-1.71-2.60-12.77-3.00-3.00-2.00-3.00-1.00-1.00-
Operating Cash Flow-2.94-1.83-2.54-2.000.050.170.10-0.93-0.13-0.11
Capital Expenditures-0.12-0.04--0.02---0.01---0.02
Free Cash Flow-3.06-1.87-2.54-2.020.050.170.10-0.93-0.13-0.14
Cash & Equivalents2.650.280.010.140.220.050.110.010.000.01
Total Debt0.394.362.786.622.682.052.960.510.190.17
Net Cash / Debt2.26-4.08-2.77-6.48-2.46-2.00-2.85-0.50-0.19-0.16
Assets3.930.630.340.471.414.084.435.084.510.01
Liabilities4.996.334.238.604.693.784.202.251.020.18
Book Value-0.98-5.63-3.89-8.13-3.280.310.222.843.49-0.17
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name BioCorRx Inc.
Country United States
CEO Brady James Granier

Stock Information

Ticker Symbol BICX
Stock Exchange US OTC
Sector Healthcare
Industry Medical Care Facilities
Unique Identifier OTCMKTS: BICX

Description

BioCorRx Inc., through its subsidiaries, provides alcoholism and opioid addiction treatment program for use in rehabilitation and treatment centers in the United States. It distributes and licenses BioCorRx recovery program, a medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant. The company is also developing BICX101, an injectable naltrexone product; and BICX102, an implantable naltrexone implant for the treatment of alcohol and opioid addiction. It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is headquartered in Anaheim, California.